iGMDRD551
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Ponatinib | CHEMBL1171837 CHEMBL2105708 | 24826800 | DB08901 | Alone | Small Molecule |
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsAzolesBCRP/ABCG2 InhibitorsBCRP/ABCG2 SubstratesCytochrome P-450 Enzyme InhibitorsEnzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsKinase InhibitorMyelosuppressive AgentsP-glycoprotein/ABCB1 InhibitorsP-glycoprotein/ABCB1 SubstratesProtein Kinase InhibitorsDrug Targets:
ABL1 (P00519)BCR (P11274)KIT (P10721)RET (P07949)TEK (Q02763)FLT3 (P36888)FGFR1 (P11362)FGFR2 (P21802)FGFR3 (P22607)FGFR4 (P22455)LCK (P06239)SRC (P12931)LYN (P07948)KDR (P35968)PDGFRA (P16234)Drug Pathways:
RTK signalingDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
7514 | XPO1 | 1 |
3845 | KRAS | 2 |
1387 | CREBBP | 1 |
5175 | PECAM1 | 1 |
7307 | U2AF1 | 1 |
25937 | WWTR1 | 1 |
7416 | VDAC1 | 1 |
2260 | FGFR1 | 4 |
2064 | ERBB2 | 1 |
3932 | LCK | 1 |
4088 | SMAD3 | 1 |
2322 | FLT3 | 6 |
2263 | FGFR2 | 9 |
1019 | CDK4 | 1 |
6389 | SDHA | 1 |
57111 | RAB25 | 1 |
4089 | SMAD4 | 1 |
4214 | MAP3K1 | 1 |
3553 | IL1B | 1 |
5156 | PDGFRA | 1 |
1938 | EEF2 | 1 |
2113 | ETS1 | 1 |
2067 | ERCC1 | 1 |
2194 | FASN | 2 |
1385 | CREB1 | 1 |
3815 | KIT | 8 |
5925 | RB1 | 1 |
4893 | NRAS | 2 |
25 | ABL1 | 31 |
581 | BAX | 1 |
Gene in drug-gene network: Network Plot
Models in Ponatinib